Skip to main content
logo
Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
11.21
-0.49 (-4.19%)
Sep 25, 2026, 12:12 PM EDT - Market open

Immix Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
802276611373247
Market Cap Growth
1097.59%355.41%-55.98%331.07%-32.18%-
Enterprise Value
571261421181551
Last Close Price
11.705.232.206.922.293.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.662.944.578.492.422.61
P/TBV Ratio
3.482.944.578.382.422.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.08--0.00
Net Debt / Equity Ratio
-1.01-1.06-1.25-1.08-1.02-0.98
Net Debt / EBITDA Ratio
5.573.340.731.091.6413.04
Net Debt / FCF Ratio
5.914.031.051.531.8111.07
Quick Ratio
24.959.932.265.0210.7587.46
Current Ratio
25.1310.012.335.3211.7090.01
Return on Equity (ROE)
-34.18%-55.00%-147.33%-106.22%-52.84%-367.80%
Return on Assets (ROA)
-20.52%-29.30%-66.11%-57.92%-31.04%-9.02%
Return on Capital Employed (ROCE)
-18.20%-31.60%-159.00%-99.60%-60.30%-7.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.01%-10.68%-35.72%-11.22%-25.80%-51.85%
FCF Yield
-4.90%-8.95%-26.06%-8.31%-23.23%-3.38%
Buyback Yield / Dilution
-61.22%-16.55%-63.11%-24.87%-278.13%-8.82%
SEC Filings: 10-K · 10-Q